0611/26SCR019-18/R6RGB
Media Highlights
From the 2026 ASCO® Annual Meeting
2
Continued ➔
Media Outlet Date Article / Coverage
AJMC 6/1/26 Results Show Giving Prophylactic Tocilizumab Reduces CRS
in Outpatient Delivery of Teclistamab, Talquetamab
Cancer Network 5/31/26 Tocilizumab Supports Outpatient Bispecific Antibody Use in
Multiple Myeloma
Clinical Trials Arena 6/1/26 ASCO26: BMS and J&J Debut Shining Multiple Myeloma Data
Peter Forsberg, MD
SCRI at Colorado Blood Cancer Institute
Media Outlet Date Article / Coverage
Cancer Network 6/2/26 HC-7366 Plus Belzutifan Shows Favorable PK/PD Profile in
Advanced ccRCC
Benjamin Garmezy, MD
SCRI
